PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

International study points to inflammation as a cause of plaque buildup in heart vessels

2012-12-03
(Press-News.org) STANFORD, Calif. — Fifteen new genetic regions associated with coronary artery disease have been identified by a large, international consortium of scientists — including researchers at the Stanford University School of Medicine — taking a significant step forward in understanding the root causes of this deadly disease. The new research brings the total number of validated genetic links with heart disease discovered through genome-wide association studies to 46.

Coronary artery disease is the process by which plaque builds up in the wall of heart vessels, eventually leading to chest pain and potentially lethal heart attacks. It is the leading cause of death worldwide.

The study, which will be published online Dec. 2 in Nature Genetics, provides insights into the molecular pathways causing coronary artery disease, which is also known as coronary atherosclerosis.

"Perhaps the most interesting results of this study show that some people may be born with a predisposition to the development of coronary atherosclerosis because they have inherited mutations in some key genes related to inflammation," said Themistocles (Tim) Assimes, MD, PhD, a Stanford assistant professor of medicine and one of the study's lead authors. "There has been much debate as to whether inflammation seen in plaque buildup in heart vessels is a cause or a consequence of the plaques themselves. Our network analysis of the top approximately 240 genetic signals in this study seems to provide evidence that genetic defects in some pathways related to inflammation are a cause."

More than 170 researchers were involved in this massive meta-analysis combining genetic data from more than 190,000 research participants. Interestingly, about a quarter of the genetic regions associated with coronary disease or heart attack were also found to be strongly associated with cholesterol, especially high levels of the so-called bad cholesterol known as LDL. Another 10 percent were associated with high blood pressure. Both of these conditions are known risk factors for coronary artery disease.

"The signals that do not point to known risk factors may be pointing to novel mechanisms of disease," Assimes said. "It is imperative that we quickly gain a better understanding of how these regions are linked to heart disease, as such understanding will greatly facilitate the development of new drugs to prevent heart disease."

Genome-wide association studies, or GWAS, were first introduced in 2005 as a way of quickly scanning the entire genome to identify differences in the DNA code, or "polymporphisms," that predispose people to various common but genetically complex diseases. Results of these studies have shown that conditions such as heart disease involve the combined, subtle effects of far more polymorphisms than initially expected, requiring multiple massive meta-analyses such as this one to reliably uncover all of these genetic signals. The hope of scientists is that by working together in ongoing worldwide collaborations, the entire genetic contribution to the cause of heart disease will eventually be identified.

"Studies like this one help provide new pathways for scientists to investigate in more detail," said co-author Thomas Quertermous, MD, a Stanford professor of medicine. "The promise is in providing better insights into the pathophysiology of this disease."

This meta-analysis study built upon previous research published last year in Nature Genetics. In that study, investigators examined 2.5 million SNPs (genetic variants at specific locations on individual chromosomes) from 14 GWA studies, which led to the discovery of 13 new gene regions associated with heart disease. Investigators looked at data from the complete genetic profiles of more than 22,000 people of European descent with heart disease and more than 64,000 healthy people.

In the new study, scientists used all information from last year's study then added to it, reaching 41,513 patients with heart disease and 65,919 control patients. To genetically fingerprint a large number of subjects in a very cost-effective manner, the researchers used a specialized genetic chip that incorporated only the top signals from the original meta-analysis of the initial 14 GWA studies.

###Quertermous is the principal Stanford investigator of the Stanford/Kaiser ADVANCE study of heart disease, which was part of the consortium involved in the research. Other Stanford authors include Joshua Knowles, MD, PhD, instructor of cardiovascular medicine; and Ben Goldstein, PhD, senior biostatistician. The Stanford/Kaiser ADVANCE study was conducted in collaboration with co-authors at the Kaiser Division of Research in Oakland and the HudsonAlpha Genome Sequencing Center (formerly the Stanford Human Genome Center).

A complete list of the funding institutions and co-authors of the work is available in the Nature Genetics paper. None of the Stanford authors reported any conflicts of interests related to this paper.

Information about Stanford's Department of Medicine, which also supported the Stanford portion of the work, is available at http://medicine.stanford.edu.

The Stanford University School of Medicine consistently ranks among the nation's top medical schools, integrating research, medical education, patient care and community service. For more news about the school, please visit http://mednews.stanford.edu. The medical school is part of Stanford Medicine, which includes Stanford Hospital & Clinics and Lucile Packard Children's Hospital. For information about all three, please visit http://stanfordmedicine.org/about/news.html.


ELSE PRESS RELEASES FROM THIS DATE:

Goodbye, fluorescent light bulbs! See your office in a new light

Goodbye, fluorescent light bulbs! See your office in a new light
2012-12-03
Say goodbye to that annoying buzz created by overhead fluorescent light bulbs in your office. Scientists at Wake Forest University have developed a flicker-free, shatterproof alternative for large-scale lighting. The lighting, based on field-induced polymer electroluminescent (FIPEL) technology, also gives off soft, white light – not the yellowish glint from fluorescents or bluish tinge from LEDs. "People often complain that fluorescent lights bother their eyes, and the hum from the fluorescent tubes irritates anyone sitting at a desk underneath them," said David Carroll, ...

Common diabetes drug may help treat ovarian cancer

2012-12-03
A new study suggests that the common diabetes medication metformin may be considered for use in the prevention or treatment of ovarian cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study found that ovarian cancer patients who took the drug tended to live longer than patients who did not take it. New treatments are desperately needed for ovarian cancer. Previous research has indicated that metformin, which originates from the French Lilac plant, may have anticancer properties. To look for an effect of the medication ...

Food allergies? Pesticides in tap water might be to blame

2012-12-03
ARLINGTON HEIGHTS, Ill. (December 3, 2012) – Food allergies are on the rise, affecting 15 million Americans. And according to a new study published in the December issue of Annals of Allergy, Asthma and Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI), pesticides and tap water could be partially to blame. The study reported that high levels of dichlorophenols, a chemical used in pesticides and to chlorinate water, when found in the human body, are associated with food allergies. "Our research shows that high levels ...

Mayo study: Common diabetes drug may treat ovarian cancer

2012-12-03
ROCHESTER, Minn. -- Diabetic patients with ovarian cancer who took the drug metformin for their diabetes had a better survival rate than patients who did not take it, a study headed by Mayo Clinic shows. The findings, published early online in the journal Cancer, may play an important role for researchers as they study the use of existing medications to treat different or new diseases. Metformin is a widely prescribed drug to treat diabetes, and previous research by others has shown its promise for other cancers. The Mayo-led study adds ovarian cancer to the list. Researchers ...

Increases in personal income important for happiness worldwide, new study says

2012-12-03
WASHINGTON – For people living in both rich and poor countries, the average person's happiness is based on a combination of individual wealth, possessions and optimism, according to an analysis of new worldwide survey findings published by the American Psychological Association. A country's gross domestic product per capita did not have as much of an impact on the average person's happiness, according to research based on responses of 806,526 people in 135 countries from 2005 to 2011. Happiness expert and psychologist Edward Diener, PhD, of the University of Illinois, ...

Public Relations and Social Media Expert to Advise Nonprofit Leaders at New Jersey Conference

2012-12-03
Public relations and social media expert Joyce Luhrs will provide free one-on-one consulting about public relations and publicity to nonprofit leaders attending the Center for Non-Profits' annual conference, Riding the Winds of Change: Harnessing Our Collective Power. Nonprofit leaders and executive directors of organizations throughout New Jersey will participate in the daylong event on Wednesday, December 5, 2012 at the Crowne Plaza Monroe in Jamesburg, New Jersey. A public relations, marketing and grants consultant with over 20 years experience, Ms. Luhrs is volunteering ...

Dr. James Perdue Releases New Book and New Website For Those Who Have Their Dreams

2012-12-03
Dr. James Perdue an, author, public speaker and inspirational motivator has launched a new book to support the new addition to his website "A One More Play" new print version published by Westbow Press. Many people lose sight of their dreams especially those that have suffered a disability as Dr. Perdue. Some people deny their dreams or simply fall into depression because of certain failures. After becoming a quadriplegic at the age of nineteen, James persevered past his paralysis by completing his doctorate degree, becoming an educator and coach, and now ...

Fine Art Photographer Steve Giovinco in Groundbreaking Museum Exhibition "the kids are alright"

2012-12-03
Exploring complex contemporary family life and couples through the lens of photography, fine art photographer Steve Giovinco is included in the stunning museum exhibition, "the kids are alright." The fine art photography show is at the John Michael Kohler Arts Center, Sheboygan, Wisconsin and runs through January 20, 2012. The exhibition concentrates on contemporary photography and time-based media by nearly 40 artists who bring the bedrock theme of family into the 21st Century. THE KIDS ARE ALRIGHT includes award winning and widely exhibiting photographers ...

Small Business Payroll System: EzPaycheck Improved To Helps Small Firms Do More For Less

2012-12-03
"Payroll tax processing and year-end tax reporting should not be a pain for small business owners," said Halfpricesoft.com founder Dr. Ge. "We believe small business software should be simple, reliable and affordable - so we intentionally engineered this software for business owners who are not professional accountants and payroll tax experts." EzPaycheck, the payroll and check printing software, from Halfpricesoft.com gives small and mid-size businesses another option to calculate payroll tax, print paychecks and file tax forms easily and quickly. ...

Ukietech Team Helps Orphans on Saint Nicholas Day

2012-12-03
The Maltese Cross Corps charity organization has a long, great tradition of organizing the "Saint Nicholas Goes to Orphans" action shortly before Saint Nicholas Day on December 19th. The mission of the action is to raise funds and get presents for orphans and disadvantaged children. Every child in the Ukraine looks forward to the night of December 19th, when Saint Nicholas, the Ukrainian version of Santa Claus, comes to their room and leaves presents under their pillow. Also, on this day, children write letters to Saint Nicholas with their list of presents. This ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] International study points to inflammation as a cause of plaque buildup in heart vessels